Corden Pharma - A Full-Service CDMO Employee Directory
Pharmaceutical ManufacturingBasel-Stadt, Switzerland1001-5000 Employees
CordenPharma is a full-service contract development and manufacturing organization (CDMO) in the pharmaceutical manufacturing industry, providing APIs, lipid excipients, drug products, and packaging. The company operates a network of cGMP facilities across Europe and the United States, organized under six technology platforms: Peptides, Lipids & Carbohydrates, Oligonucleotides, Injectables, Highly Potent & Oncology, and Small Molecules. Headquartered in Basel, Switzerland (71 Aeschenvorstadt, Basel-Stadt 4051), CordenPharma employs between 1,001 and 5,000 people. Astorg Partners acquired CordenPharma International in 2022, and in 2026 the group expanded its footprint with new production sites in the United States and China and by acquiring AmbioPharm’s peptide API manufacturing facilities in North Augusta, South Carolina, USA and Shanghai, China. The company maintains a global footprint with ongoing capacity expansion initiatives, including activities related to GLP-1 peptide production capacity as referenced in recent news.
1-888-653-2347 
support@leadiq.com 
